Evi Struble

Dr. Evi Struble

Laboratory of Plasma Derivatives, Division of Plasma Protein Therapeutics, Office of Tissues and Advanced Therapies, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration
orcid

Biography

Dr. Struble earned a PhD in Biophysics from Johns Hopkins University followed by a post-doctoral training at the National Institute of Standards and Technology, Gaithersburg, Md. She is a Research Pharmacologist in CBER, FDA, where she performs reviews of regulatory applications and mission-related research. Dr. Struble’s regulatory responsibilities include advice and evaluation of preclinical studies for plasma protein therapeutics, including hyperimmune globulin preparations for infectious disease indications. As a research scientist, Dr. Struble investigates appropriate animal and in vitro models for assessing the safety and efficacy of antibody drugs during pregnancy. Her most recent work has been focused on therapies for Zika viral (ZIKV) infections.

Affiliations

No affiliation has been shared yet.

Honors and Awards

No honors or awards have been shared yet.

Experience

No experience has been shared yet.